<DOC>
	<DOCNO>NCT01286090</DOCNO>
	<brief_summary>The purpose study assess effectiveness cisapride improve symptom associate gastroparesis ( stomach disorder ) patient diabetes mellitus .</brief_summary>
	<brief_title>An Efficacy Safety Study Cisapride Improving Symptoms Associated With Gastroparesis Patients With Diabetes Mellitus</brief_title>
	<detailed_description>This double-blind ( neither physician patient know name assign treatment ) study determine effectiveness cisapride tablet compare placebo tablet ( tablet identical appearance cisapride contain active drug ) improving symptom associate diabetic gastroparesis administer orally ( mouth ) patient insulin dependent non-insulin dependent diabetes mellitus . Gastroparesis disorder also call delay gastric empty , stomach take long empty food small intestine digestion . Symptoms gastroparesis may include vomit , nausea , early feeling fullness bite food , weight loss due poor absorption nutrient low calorie intake , abdominal bloating , poor glycemic ( blood sugar ) control , lack appetite , pain stomach area . Patients take study drug ( one 10-mg tablet cisapride , one tablet placebo ) , orally , 4 time day , period 8 week . Study drug take approximately 15 minute meal , beverage , go bed .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Cisapride</mesh_term>
	<criteria>Diagnosed insulin dependent noninsulin dependent diabetes mellitus Experienced inadequate response , intolerant , treatment least one previous drug therapy gastroparesis Have exacerbation gastroparesis symptom require medical attention Demonstrate delay gastric empty assessed [ 113C ] Sodium Acetate Breath Test within 14 day randomization Received prior treatment cisapride Have glycosylated hemoglobin ( HbA1c ) &gt; 10 % screening , determine clinical laboratory test Have upper gastrointestinal ( GI ) pathology diabetic gastroparesis would require therapy provide trial Have organic/neurological disease suspect cause gastroparesis , diabetes Currently vomit , receive therapy severe exacerbation gastroparesis , would prevent patient receive oral therapy diet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Cisapride ( PREPULSID )</keyword>
	<keyword>Placebo</keyword>
	<keyword>Diabetes mellitus</keyword>
	<keyword>Diabetic gastroparesis</keyword>
</DOC>